Robuta

Sponsor of the Day: Jerkmate
https://endpoints.news/fda-warns-immunitybio-over-misleading-podcast-with-patrick-soon-shiong/ FDA warns ImmunityBio over misleading podcast with Patrick Soon-Shiong FDA warns ImmunityBio and Patrick Soon-Shiong over misleading Anktiva cancer drug ads on TV and podcast, claiming it can treat all cancers beyond approved use patrick soon shiongfda warnsimmunitybiomisleadingpodcast https://www.financialcontent.com/article/newmediawire-2026-4-6-immunitybio-inc-ibrx-investors-have-opportunity-to-lead-securities-fraud-class-action-lawsuit ImmunityBio, Inc. (IBRX) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit |... Apr 6, 2026 - Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. securities fraud classimmunitybio incaction lawsuitibrxinvestors https://immunitybio.com/founders-vision/ Founder's Vision - ImmunityBio foundervisionimmunitybio https://www.financialcontent.com/article/thenewswire-2026-4-6-immunitybio-inc-ibrx-investors-have-opportunity-to-lead-securities-fraud-class-action-lawsuit ImmunityBio, Inc. (IBRX) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit |... Apr 6, 2026 - Did you buy IBRX securities between January 19, 2026, and March 24, 2026? securities fraud classimmunitybio incaction lawsuitibrxinvestors https://apnews.com/article/patrick-soonshiong-immunitybio-anktiva-cancer-ebb9a297655dced61487b0317e320307 ImmunityBio Anktiva cancer claims: FDA flags Patrick Soon-Shiong's comments | AP News Mar 24, 2026 - Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick Soon-Shiong about one of his company's... patrick soon shiongcancer claimsfda flagsap newsimmunitybio https://www.biospace.com/press-releases/immunitybio-addresses-fda-correspondence-and-reaffirms-commitment-to-advertising-compliance ImmunityBio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance -... reaffirms commitmentadvertising complianceimmunitybioaddressesfda https://www.statnews.com/pharmalot/2026/03/24/fda-slams-soon-shiong-immunitybio-false-misleading-claims/ FDA slams Soon-Shiong, ImmunityBio for 'misleading' drug claims Mar 27, 2026 - The FDA sent a warning letter in which it maintained 'material facts' and risks associated with the cancer drug were omitted. soon shiongfdaslamsimmunitybiomisleading https://immunitybio.com/human-papillomavirus/ Human Papillomavirus - ImmunityBio human papillomavirusimmunitybio https://markets.financialcontent.com/stocks/quote?Symbol=537%3A2578296765 FinancialContent - ImmunityBio, Inc. - Common Stock (Nasdaq:IBRX) Stock Quote View live stock data, charting, and news for ImmunityBio, Inc. - Common Stock (Nasdaq:IBRX) inc common stockfinancialcontentimmunitybionasdaqibrx https://immunitybio.com/ Immunotherapy by ImmunityBio - Cancer Vaccine Research Apr 21, 2026 - We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products. cancer vaccineimmunotherapyimmunitybioresearch